Status:
COMPLETED
SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism
Lead Sponsor:
University Hospital Tuebingen
Collaborating Sponsors:
Abbott
Conditions:
Spinal Cord Stimulation (SCS)
Blood Glucose Metabolism
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
In 1967 spinal cord stimulation (SCS) for the treatment of chronic neuropathic pain was established. Today various pain syndromes like the failed back surgery syndrome (FBSS), the complex regional pai...
Eligibility Criteria
Inclusion
- Understand and voluntarily sign an informed consent document prior to any study related assessments/procedures.
- HbA1c \< 6,0%
- state after implantation of an neuromodulation device
- Clinical routine blood parameters within the normal ranges
Exclusion
- diabetes mellitus
- Acute diseases such as infections (e.g.) within the last four weeks
- Hb \< 13 g/dl
- anamnestic heparin-induced thrombocytopenia
- any neurologic or psychiatric disease
Key Trial Info
Start Date :
July 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04272411
Start Date
July 11 2019
End Date
June 1 2020
Last Update
May 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hopsital Tübingen
Tübingen, Germany, 72076